Morning light treatment for inflammatory bowel disease: a clinical trial
Abstract Background Inflammatory bowel disease (IBD) affects over 3 million Americans and has a relapsing and remitting course with up to 30% of patients experiencing exacerbations each year despite the availability of immune targeted therapies.An urgent need exists to develop adjunctive treatment approaches to better manage IBD symptoms and diseas